PPMD 2024: PTC to seek FDA approval of ataluren for DMD
Note: This story was updated Oct. 22, 2024, to remove a reference to the therapy being pulled from the market in Europe. Although this was the initial recommendation, the therapy has remained available in Europe. PTC Therapeutics plans to soon ask the U.S. Food and Drug Administration (FDA)…